The world is Changing every day invest in your future today. This was just a movie some years ago but today it has come to reality. Nothing is impossible, crypto investments has changed life and it is still changing life's
Bullish
W
I don't think that PTE has another 10% in gains in it. Looks pretty bad here. I actually found (http://Achieverspot.tech) the other day and their stocks are way better...
They'll do anything to do an offering. They have low cash. Expect the unexpected
J
With the FDA on board, PTE is on track to fully validate SkinTE ! Huge DFU market !
J
Great news! I was about wondering how much longer it would take!!!!
S
8-K today: As a result of the transactions described above, the Company and its subsidiaries are no longer engaged in the business of offering preclinical research and veterinary services, Utah CRO now holds the promissory note described above in the principal amount of $400,000, which was consideration for sale of the IBEX common shares, and the Company received for the account of IBEX Property net cash proceeds of $2.57 million, after deducting closing costs and advisory fees, from sale of the Property under the Real Estate Agreement. The Company evaluated the transaction and concluded that the disposition of IBEX and the Property was not “significant” under the criteria set forth in Rule 11-01(b) of Regulation S-X.
Bullish
s
PTE looks like it is about to drop. Be careful guys. I have been reading (http://Achieverspot.tech) and their stocks have been doing way better.
E
Shall i buy?
A
PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers
S
SALT LAKE CITY, May 3, 2022
SALT LAKE CITY, May 3, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) today announced the enrollment of the first subject in the Phase III pivotal study evaluating SkinTE in the investigational use of treatment of Wagner grade 2 diabetic foot ulcers (DFUs), entitled "Closure Obtained with Vascularized Epithelial Regeneration for DFUs with SkinTE," or "COVER DFUs."
COVER DFUs will enroll up to 100 subjects at up to 20 clinical sites in the United States. Subjects will be randomized to one of two treatment groups, receiving either SkinTE plus the standard of care (SOC) or the SOC alone. The primary endpoint is the incidence of DFUs closed at 24 weeks. Secondary endpoints include percent area reduction (PAR) at 4, 8, 12, 16 and 24 weeks; improved quality of life, including social isolation, depression, odor, improved function, ambulation, and return to activities based on changes in wound quality of life; and new onset infection of the DFU requiring treatment with topical and/or systemic antibiotics.
Bullish
J
Let the squeeze begin
M
I’ve been day trading for years and I’m so glad I finally found (http://the-alphatrader.com/)! . They’re pre-market watchlists cover all the latest market-moving news, and they don’t beat you down with tons of ads. Highly recommend!
o
Who's ready for $.17 cents today? Eskeetit
A
Trading and investing literally has to do with determination,consistency and having a mindset to never give up is key. Just like a battle or war, we take loss in our stride and continue to fight. Never give up, never get too comfortable and you'll be surprised by the outcome. Forex trading remains the best.
y
It should be over 0.3 (last offering price)
j
Take your pick guys , Biomed stocks have been trending big time these past few days. PTE absolutely nailed it on Tuesday and is most certainly ready to do it again. I’m in and waiting for everyone else go jump aboard. PTE is a biotechnology company developing tissue products and biomaterials, just announced their fourth U.S. Patent building and protecting their intellectual property. Which goes hand and hand with their effort to advance regulatory approval of Skin TE Through the first of two 3 Phase clinical studies. As the biotech sector rebounds from cyclical lows, institutional investors are increasingly eyeing early-stage biotech stocks like PTE for early upside potential. GLTA!
future today. This was just a movie some years
ago but today it has come to reality.
Nothing is impossible, crypto investments has
changed life and it is still changing life's
Whats>App +1 (267) 946‑7650 via te*le*gram@kochmorris2
https://stockreport.tips/Bullish-Charts
As a result of the transactions described above, the Company and its subsidiaries are no longer engaged in the business of offering preclinical research and veterinary services, Utah CRO now holds the promissory note described above in the principal amount of $400,000, which was consideration for sale of the IBEX common shares, and the Company received for the account of IBEX Property net cash proceeds of $2.57 million, after deducting closing costs and advisory fees, from sale of the Property under the Real Estate Agreement. The Company evaluated the transaction and concluded that the disposition of IBEX and the Property was not “significant” under the criteria set forth in Rule 11-01(b) of Regulation S-X.
SALT LAKE CITY, May 3, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) today announced the enrollment of the first subject in the Phase III pivotal study evaluating SkinTE in the investigational use of treatment of Wagner grade 2 diabetic foot ulcers (DFUs), entitled "Closure Obtained with Vascularized Epithelial Regeneration for DFUs with SkinTE," or "COVER DFUs."
COVER DFUs will enroll up to 100 subjects at up to 20 clinical sites in the United States. Subjects will be randomized to one of two treatment groups, receiving either SkinTE plus the standard of care (SOC) or the SOC alone. The primary endpoint is the incidence of DFUs closed at 24 weeks. Secondary endpoints include percent area reduction (PAR) at 4, 8, 12, 16 and 24 weeks; improved quality of life, including social isolation, depression, odor, improved function, ambulation, and return to activities based on changes in wound quality of life; and new onset infection of the DFU requiring treatment with topical and/or systemic antibiotics.